5 April 2011
JUDGES SCIENTIFIC plc
("Judges Scientific", "Judges" or the "Company")
Director/PDMR Shareholding
The Company announces that David Cicurel, a director and the Chief Executive Officer of the Company, has sold 70,400 Ordinary Shares to another member of a concert party of shareholders deemed to exist at Judges. The transaction took place today at a price of 455p per share. The purpose of this sale was to facilitate compliance with pension regulations.
His interest in the Company is now 455,956 Ordinary Shares representing 10.91% of the issued Ordinary Share capital. He also holds 4,166,667 Convertible Redeemable Shares representing 83.3% of the issued shares of that class. His potential holding of Ordinary Shares, assuming he and he alone converted all of his Convertible Redeemable Shares into new Ordinary Shares, would be 19.9985% of the Ordinary Share capital as enlarged by such conversion.
Enquiries:
David Cicurel, CEO, Judges Scientific: Tel: 01342 323 600
Pascal Keane, Shore Capital: Tel: 020 7408 4090
Melvyn Marckus, Cardew Group: Tel: 07775 896 491
Websites:
Judges Scientific: www.judges.uk.com